These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19274523)

  • 1. Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model.
    Higaki S; Watanabe K; Itahashi M; Shimomura Y
    Curr Eye Res; 2009 Mar; 34(3):171-6. PubMed ID: 19274523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
    Itahashi M; Higaki S; Shimomura Y
    Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty.
    Zheng X; Marquart ME; Loustch JM; Shah P; Sainz B; Ray A; O'Callaghan RJ; Kaufman HE; Hill JM
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2490-7. PubMed ID: 10509641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acyclovir on thermal stress-induced herpesvirus reactivation.
    Gebhardt BM; Kaufman HE; Hill JM
    Curr Eye Res; 2004; 29(2-3):137-44. PubMed ID: 15512960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylsalicylic acid reduces viral shedding induced by thermal stress.
    Gebhardt BM; Varnell ED; Kaufman HE
    Curr Eye Res; 2004; 29(2-3):119-25. PubMed ID: 15512958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E modulates establishment of HSV-1 latency and survival in a mouse ocular model.
    Bhattacharjee PS; Neumann DM; Stark D; Thompson HW; Hill JM
    Curr Eye Res; 2006 Sep; 31(9):703-8. PubMed ID: 16966142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aminoguanidine, a nitric oxide synthase inhibitor, on ocular infection with herpes simplex virus in Balb/c mice.
    Benencia F; Courrèges MC; Gamba G; Cavalieri H; Massouh EJ
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1277-84. PubMed ID: 11328740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-specific accumulation of latency-associated transcripts in herpes virus-infected rabbits.
    O'Brien WJ; Tsao LS; Taylor JL
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1847-53. PubMed ID: 9727407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.
    Waterbury LD; Silliman D; Jolas T
    Curr Med Res Opin; 2006 Jun; 22(6):1133-40. PubMed ID: 16846546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic acyclovir effectively reduces herpes simplex virus type 1 reactivation after exposure of latently infected mice to ultraviolet B.
    Blatt AN; Laycock KA; Brady RH; Traynor P; Krogstad DJ; Pepose JS
    Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3459-65. PubMed ID: 8225880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of immunosuppression on gene expression in the HSV-1 latently infected mouse trigeminal ganglion.
    Higaki S; Gebhardt BM; Lukiw WJ; Thompson HW; Hill JM
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1862-9. PubMed ID: 12036991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of DNA encoding IFN-alpha1 against corneal HSV-1 infection.
    Noisakran SJ; Carr DJ
    Curr Eye Res; 2000 May; 20(5):405-12. PubMed ID: 10855035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A replication competent HSV-1(McKrae) with a mutation in the amino-terminus of glycoprotein K (gK) is unable to infect mouse trigeminal ganglia after cornea infection.
    Saied AA; Chouljenko VN; Subramanian R; Kousoulas KG
    Curr Eye Res; 2014 Jun; 39(6):596-603. PubMed ID: 24401006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The survival of herpes simplex virus in preserved murine corneas.
    Robert PY; Ducher V; Pleyer U; Denis F; Adenis JP; Ranger-Rogez S
    Ophthalmic Res; 2008 Oct; 40(6):329-32. PubMed ID: 18698148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetics of herpes virus on the ocular surface and suppression of its reactivation.
    Shimomura Y; Higaki S
    Cornea; 2011 Oct; 30 Suppl 1():S3-7. PubMed ID: 21912227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral valaciclovir on herpetic keratitis.
    Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
    Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCR assessment of HSV-1 corneal infection in animals treated with rose bengal and lissamine green B.
    Stroop WG; Chen TM; Chodosh J; Kienzle TE; Stroop JL; Ling JY; Miles DA
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2096-102. PubMed ID: 10892849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray analysis in the HSV-1 latently infected mouse trigeminal ganglion.
    Higaki S; Deai T; Fukuda M; Shimomura Y
    Cornea; 2004 Nov; 23(8 Suppl):S42-7. PubMed ID: 15448479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation.
    Gebhardt BM; Varnell ED; Kaufman HE
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):114-20. PubMed ID: 15857277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular HSV-1 latency, reactivation and recurrent disease.
    Toma HS; Murina AT; Areaux RG; Neumann DM; Bhattacharjee PS; Foster TP; Kaufman HE; Hill JM
    Semin Ophthalmol; 2008; 23(4):249-73. PubMed ID: 18584563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.